simbha

simbha

Oversold with a W on oscillator. Historically gave a nice risk/reward at these levels.

simbha

Chart shows over reaction and intentional crash and ignore COVID 2023 revenues to ZERO. Close to oversold on RSI.

simbha

It should bounce back with multiple extentions done.

simbha

Rest all on the chart. Just ride on any pull backs.

simbha

Weekly/Daily double bottoms. Setting nice harmonic for a W-patterns.

simbha

PFE valuation was recalculated and corrected itself after all institutions accumulated it by dragging PPS to 34. Even if it requires a backtest to 43, it might be too fast and quick bounce back heading into 50s. Simple fibonacci targets are 50+.

simbha

Rest all in chart

simbha

Rest all on the chart.

simbha

MACD signal cross. Fib 0.618 held well. Closed above 50SMA. Slow mover but next leg should be fast.

simbha

First bounce likely here. Keep watching for a cosolidation or double bottom or +ve divergences. Weekly MACD is not in good shape.

simbha

1.618 retracement(67) looks like typical earnings drop which we see across all biotechs and health care stocks. Always play both sides since earnings are kinda gamble.

simbha

Vaccine Chickens Coming Home To Roost. Slow mover at the bottoms but it can run like a Chicken With Its head Cut Off after the next break above 43.

simbha

IBB and XBI broke out. Will EXEL follow the sector trend with an excellent clinical read outs across multiple oncology fields?

simbha

Monthly 50EMA support @17.40 We had a similar support and bounce in Nov-2018

simbha

Rest all on chart.

simbha

Rest all on chart. I am expecting next leg up towards 25 after this Dec-21 options expiry. Support range : 18~19.

simbha

Interesting levels to watch.

simbha

Looking very good. Earnings breakout likely and rally back to 45+